JOHN RAHHAL: Open Payments
NPI 1164490223 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 14 payments from 9 companies in 2025. Trend: 2023 $242 · 2024 $186 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $45 |
| Noven Therapeutics, LLC | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $36 |
| Alkermes, Inc. | 1 | $25 |
| Sage Therapeutics, LLC | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Tris Pharma Inc | 1 | $19 |
Products named: Auvelity, Xelstrym, AUSTEDO XR, VRAYLAR, ARISTADA, ZURZUVAE, Jornay PM, SPRAVATO.
Industry payments across OK — which companies pay providers there.
